A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Episode 3

The Multidisciplinary Approach to CAR T-Cell Therapy for B-ALL

Experts discuss the composition of their multidisciplinary hematologic oncology team, highlighting collaboration among hematologists, oncologists, nurses, pathologists, and other specialists to provide comprehensive patient care.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: CAR T-cell Therapy for B-ALL
    EP. 2: Navigating Treatment Selections for B-ALL: Insights From the Moffitt Cancer Center
    Now Viewing
    EP. 3: The Multidisciplinary Approach to CAR T-Cell Therapy for B-ALL
    EP. 4: CAR T-Cell Therapy for B-ALL: Roles Within the Multidisciplinary Care Team
    EP. 5: Optimizing Molecular Profiling for B-ALL Treatment
    EP. 6: Multidisciplinary Clinical Perspectives: Factors That Influence CAR T-Cell Sequencing in B-ALL
    EP. 7: Considerations Regarding Bridging Therapy for B-ALL CAR T-Cell Treatment
    EP. 8: Obe-Cel for B-ALL: Insights Regarding Persistence, Toxicity, and Remission
    EP. 9: CAR T-Cell Therapy Decisions in B-ALL: The Role of Obe-Cel in B-ALL Treatment
    EP. 10: Managing Immunotoxicities With CAR T-Cell Therapy for B-ALL
    EP. 11: Treatment Sequencing Decisions for B-ALL: Perspectives From Moffitt Cancer Center
    EP. 12: Future Considerations for Treatment Sequencing in B-ALL

    Video content above is prompted by the following:

    What is the composition of your multidisciplinary hematologic oncology team at your center?

    x